JP2022550690A5 - - Google Patents

Info

Publication number
JP2022550690A5
JP2022550690A5 JP2022516686A JP2022516686A JP2022550690A5 JP 2022550690 A5 JP2022550690 A5 JP 2022550690A5 JP 2022516686 A JP2022516686 A JP 2022516686A JP 2022516686 A JP2022516686 A JP 2022516686A JP 2022550690 A5 JP2022550690 A5 JP 2022550690A5
Authority
JP
Japan
Prior art keywords
omeprazole
storage
mixture
sodium
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516686A
Other languages
English (en)
Japanese (ja)
Other versions
JP7801996B2 (ja
JP2022550690A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/059280 external-priority patent/WO2021064682A1/en
Publication of JP2022550690A publication Critical patent/JP2022550690A/ja
Priority to JP2025152489A priority Critical patent/JP2025170126A/ja
Publication of JP2022550690A5 publication Critical patent/JP2022550690A5/ja
Application granted granted Critical
Publication of JP7801996B2 publication Critical patent/JP7801996B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516686A 2019-10-04 2020-10-02 小児懸濁液製剤 Active JP7801996B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025152489A JP2025170126A (ja) 2019-10-04 2025-09-12 小児懸濁液製剤

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962911035P 2019-10-04 2019-10-04
US62/911,035 2019-10-04
US201962911689P 2019-10-07 2019-10-07
US62/911,689 2019-10-07
US202063062785P 2020-08-07 2020-08-07
US63/062,785 2020-08-07
PCT/IB2020/059280 WO2021064682A1 (en) 2019-10-04 2020-10-02 Pediatric suspension formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025152489A Division JP2025170126A (ja) 2019-10-04 2025-09-12 小児懸濁液製剤

Publications (3)

Publication Number Publication Date
JP2022550690A JP2022550690A (ja) 2022-12-05
JP2022550690A5 true JP2022550690A5 (https=) 2025-10-30
JP7801996B2 JP7801996B2 (ja) 2026-01-19

Family

ID=72744602

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022516686A Active JP7801996B2 (ja) 2019-10-04 2020-10-02 小児懸濁液製剤
JP2025152489A Pending JP2025170126A (ja) 2019-10-04 2025-09-12 小児懸濁液製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025152489A Pending JP2025170126A (ja) 2019-10-04 2025-09-12 小児懸濁液製剤

Country Status (15)

Country Link
US (2) US11826359B2 (https=)
EP (2) EP4331572A3 (https=)
JP (2) JP7801996B2 (https=)
KR (1) KR20220103711A (https=)
CN (1) CN114929222B (https=)
AU (1) AU2020358472B2 (https=)
CA (1) CA3153555A1 (https=)
ES (1) ES2974364T3 (https=)
IE (1) IE20200221A1 (https=)
IL (1) IL291778B2 (https=)
MX (1) MX2022003917A (https=)
PH (1) PH12022550798A1 (https=)
TW (1) TW202126301A (https=)
WO (1) WO2021064682A1 (https=)
ZA (1) ZA202203563B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物
GB2631129A (en) * 2023-06-23 2024-12-25 Orbit Pharma Ltd A powder composition for oral suspension of proton pump inhibitors and the method of preparing the same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20020192299A1 (en) 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
CA2448997A1 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050098526A1 (en) * 2003-11-06 2005-05-12 Robertino Catalin Two bottles/containers in one
WO2005076987A2 (en) 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
ES2283172B1 (es) * 2005-01-21 2008-08-16 Universidad De Granada Suspension extemporanea de omeprazol para via oral.
AR056062A1 (es) * 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
EP2068854A2 (en) 2006-07-29 2009-06-17 Graceway Pharmaceuticals, LLC Business method to treat and/or prevent a gastric acid disorder with a proton pump inhibitor (ppi) and a cholinergic agonist to induce rapid onset of ppi action with or without food
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
JP2011512416A (ja) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
JP5248614B2 (ja) 2008-09-01 2013-07-31 株式会社フレッシュ キャップおよびキャップ付き容器
PL2827843T3 (pl) * 2012-03-20 2016-11-30 Sposób wytwarzania dojelitowych alginianowych mikrokapsułek poprzez żelowanie jonowe zawierających diklofenak lub jedną z jego soli oraz zawierającej je wielocząsteczkowej kompozycji farmaceutycznej
GB2513172A (en) 2013-04-18 2014-10-22 Nupharm Lab Ltd Liquid dosage form and delivery system
BR112017001968A2 (pt) 2014-07-30 2017-11-21 Sun Pharmaceutical Ind Ltd embalagem de duas câmaras para uma composição farmacêutica líquida oral de múltiplas doses
CA2984725A1 (en) * 2015-05-01 2016-11-10 Sun Pharmaceutical Industries Limited Dual-chamber pack for extended release suspension compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions
US11207307B2 (en) 2016-06-16 2021-12-28 Azurity Pharmaceuticals, Inc. Composition and method for proton pump inhibitor suspension
US10137111B2 (en) * 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物

Similar Documents

Publication Publication Date Title
US4321253A (en) Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
US3970750A (en) Effervescent potassium chloride composition
JPH0482832A (ja) 医薬組成物
JPH0155244B2 (https=)
HU196708B (en) Process for producing pharmaceutical composition comprising omeprazol and suitable for treating deseases of the digestive system
KR20130117761A (ko) 간단한 투약을 위한 인산염 결합제 조성물
US20100183730A1 (en) High dose composition of ursodeoxycholic acid
JP2022550690A5 (https=)
JPH11504911A (ja) アモキシシリンおよびクラブラン酸含有の組成物
US9034382B2 (en) Oseltamivir phosphate granule and preparation method thereof
JP2025170126A (ja) 小児懸濁液製剤
US5262169A (en) Tablets and granulates containing mesna as active substance
ES2202915T3 (es) Composiciones farmaceuticas que comprenden zafirlukast.
US5252341A (en) Tablets and granulates containing mesna as active substance
US20140349948A1 (en) Treatment of Chronic Constipation
US5358718A (en) Tablet containing mesna as active substance and method of making same
RU2812137C2 (ru) Способ стабилизации влагочувствительного фармацевтического вещества и его стабилизированный препарат
JP2022184791A (ja) オセルタミビルを含む医薬組成物及びその製造方法
JPH02207A (ja) 塩酸ブロムヘキシン含有製剤
BR112019011966A2 (pt) composição aprimorada de lansoprazol e simeticona e processo para preparação